Literature DB >> 15132411

Overview, prevention, and treatment of rabies.

Daniel G Hankins1, Julia A Rosekrans.   

Abstract

Rabies is a uniformly fatal viral encephalitis that causes 30,000 to 70,000 deaths worldwide each year. Prevention is the primary approach to the disease. In the United States, 25,000 to 40,000 people are treated annually for exposure to rabid or potentially rabid animals at a per-patient cost exceeding 1000 dollars. Rabies is transmitted usually by saliva from infected animal bites. However, recent findings that rabies can be transmitted from bats to humans by relatively casual contact has resulted in dramatic changes in guidelines from the Centers for Disease Control and Prevention for postexposure prophylaxis. We review the 5 clinical stages of rabies, current methods of diagnosis, and prevention in animal reservoirs and in humans. We also discuss the use of rabies immune globulin and active and passive vaccinations for preexposure prophylaxis and postexposure treatment of rabies. Human exposure to rabies will always be a possibility, but methods to prevent the disease both before and after exposure to the virus are safe and readily available.

Entities:  

Mesh:

Year:  2004        PMID: 15132411     DOI: 10.4065/79.5.671

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  18 in total

1.  Avoiding rabies.

Authors:  Derrick Pounder
Journal:  BMJ       Date:  2005-09-03

2.  NEUROLOGICAL INFECTIONS IN THE RETURNING INTERNATIONAL TRAVELER.

Authors:  May H Han; Melanie Walker; Joseph R Zunt
Journal:  Continuum (Minneap Minn)       Date:  2006-04

Review 3.  Prophylaxis of human hydrophobia in South Korea.

Authors:  Yang Ree Kim
Journal:  Infect Chemother       Date:  2014-09-24

Review 4.  Infections of the Central Nervous System in Returning Travelers and Immigrants.

Authors:  Haley Thompson; Kiran Thakur
Journal:  Curr Infect Dis Rep       Date:  2017-10-03       Impact factor: 3.725

5.  Neurologic Manifestations of COVID-19.

Authors:  Farnaz Delavari; Farnaz Najmi Varzaneh; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Inadequate antibody response to rabies vaccine in immunocompromised patient.

Authors:  Eran Kopel; Gal Oren; Yechezkel Sidi; Dan David
Journal:  Emerg Infect Dis       Date:  2012-09       Impact factor: 6.883

7.  Efficiency of Matricaria chamomilla CH12 and number of doses of rabies vaccine on the humoral immune response in cattle.

Authors:  Luis Souza de Souza Reis; Neuza Maria Frazatti-Gallina; Rosana de Lima Paoli; Rogerio Giuffrida; Avelino Albas; Eunice Oba; Paulo Eduardo Pardo
Journal:  J Vet Sci       Date:  2008-12       Impact factor: 1.672

Review 8.  Strategic model of national rabies control in Korea.

Authors:  Yeotaek Cheong; Bongjun Kim; Ki Joong Lee; Donghwa Park; Sooyeon Kim; Hyeoncheol Kim; Eunyeon Park; Hyeongchan Lee; Chaewun Bae; Changin Oh; Seung-Yong Park; Chang-Seon Song; Sang-Won Lee; In-Soo Choi; Joong-Bok Lee
Journal:  Clin Exp Vaccine Res       Date:  2013-12-18

9.  The burden of rabies in Tanzania and its impact on local communities.

Authors:  Maganga Sambo; Sarah Cleaveland; Heather Ferguson; Tiziana Lembo; Cleophas Simon; Honorati Urassa; Katie Hampson
Journal:  PLoS Negl Trop Dis       Date:  2013-11-07

10.  Insights and efforts to control rabies in Zambia: Evaluation of determinants and barriers to dog vaccination in Nyimba district.

Authors:  Carolyn Patricia Mulipukwa; Boyd Mudenda; Allan Rabson Mbewe
Journal:  PLoS Negl Trop Dis       Date:  2017-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.